Evaluation of the humoral immune response in BALB/c mice immunized with a naked DNA vaccine anti-methicillin-resistant Staphylococcus aureus

Genetics and Molecular Research

Volumn 5, Issue 3, 2006, Pages 503-512

  Roth, D M ^a   Senna, J P M ^b   Machado, D C ^c  

^a MONASH UNIVERSITY   (Australia)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Antibodies; DNA vaccine; Methicillin resistant staphylococcus aureus; PBP2a

Indexed keywords

DNA VACCINE; VANCOMYCIN;

ANIMAL CELL; ANTIBIOTIC RESISTANCE; ARTICLE; BLOOD ANALYSIS; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOUSE; NONHUMAN;

ANIMALS; ANTIBODIES, BACTERIAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; METHICILLIN RESISTANCE; MICE; MICE, INBRED BALB C; PENICILLIN-BINDING PROTEINS; PEPTIDE SYNTHASES; POLYMERASE CHAIN REACTION; STAPHYLOCOCCAL VACCINES; STAPHYLOCOCCUS AUREUS; VACCINES, DNA;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;

EID: 33748588672     PISSN: 16765680     EISSN: 16765680     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Beck WD, Berger-Bächi B and Kayser FH (1986). Additional DNA in methicillin-resistant Staphylococcus aureus and molecular cloning of mec-specific DNA. J. Bacteriol. 165: 373-378.
2. Cohen ML (1986). Staphylococcus aureus: biology, mechanism of virulence, epidemiology. J. Pediatr. 108: 796-799.
3. Condon C, Watkins SC, Celluzi CM, Thompson K, et al. (1996). DNA based immunization by in vivo transfection of dendritic cells. Nat. Med. 2: 1122-1128.
4. Donnelly JJ, Ulmer JB, Shiver JW and Liu MA (1999). DNA vaccines. Annu. Rev. Immunol. 15: 617-648.
5. Estcourt MJ, McMichael AJ and Hanke T (2004). DNA vaccines against human immunodeficiency virus type 1. Immunol. Rev. 199: 144-155.
6. Fontana R (1985). Penicillin-binding proteins and the intrinsic resistance to beta-lactams in gram-positive cocci. J. Antimicrob. Chemother. 16: 412-416.
7. Goffin C and Ghuysen JM (1998). Multimodular penicillin-binding proteins: an enigmatic family of orthologs and paralogs. Microbiol. Mol. Biol. Rev. 62: 1079-1093.
8. Greenberg D, Bayer A, Cheung A and Ward J (1989). Protective efficacy of protein A-specific antibody against bacteremic infection due to Staphylococcus aureus in an infant rat model. Infect. Immun. 57: 1113-1118.
9. Grillot-Courvalin C, Goussard C and Courvalin P (1999). Bacteria as gene delivery vectors for mammalian cells. Curr. Opin. Biotechnol. 10: 477-481.
10. Herrmann JE (2005). DNA vaccines against enteric infections. Vaccine 24: 3705-3708.
11. Hiramatsu K, Cui L, Kuroda M and Ito T (2001). The emergence and evolution of methicillin-resistant Staphylococcus aureus. Trends Microbiol. 9: 486-493.
12. Jevons MP (1961). Celbenin-resistant staphylococci. BMJ 1: 124-125.
13. Lee JC, Perez NE, Hopkins CA and Pier GB (1988). Purified capsular polysaccharide-induced immunity to Staphylococcus aureus infection. J. Infect. Dis. 157: 723-731.
14. Lima KM, Dos Santos SA, Rodrigues JM and Silva CL (2004). Vaccine adjuvant: it makes the difference. Vaccine 22: 2374-2379.
15. Liu C, Kokuho T, Kubota T, Watanabe S, et al. (2001). DNA mediated immunization with encoding the nucleoprotein gene of porcine transmissible gastroenteritis virus. Virus Res. 28: 75-82.
16. Mamo W, Jonsson P, Flock JI, Lindberg M, et al. (1994). Vaccination against Staphylococcus aureus mastitis: immunological response of mice vaccinated with fibronectin-binding protein (FnBP-A) to challenge with Staphylococcus aureus. Vaccine 12: 988-992.
17. Manickan E, Karem KL and Rouse BT (1997). DNA vaccines - a modern gimmick or a boon to vaccinology? Crit. Rev. Immunol. 17: 139-154.
18. McKenney D, Pouliot KL, Wang Y, Murthy V, et al. (1999). Broadly protective vaccine for Staphylococcus aureus based on an in vivo-expressed antigen. Science 284: 1523-1527.
19. Navarre WW and Schneewind O (1999). Surface proteins of gram-positive bacteria and mechanisms of their targeting to the cell wall envelop. Microbiol. Mol. Biol. Rev. 63: 174-229.
20. Pearson H (2002). 'Superbug' hurdles key drug barrier. Nature 418: 469.
21. Reynolds PE and Fullers C (1986). Methicillin resistant strains of Staphylococcus aureus; presence of an identical additional penicillin-binding protein in all strains examined. FEMS Microbiol. Lett. 33: 251-254.
22. Senna JP, Roth DM, Oliveira JS, Machado DC, et al. (2003). Protective immune response against methicillin resistant Staphylococcus aureus in a murine model using a DNA vaccine approach. Vaccine 21: 2661-2666.
23. Sheagren JN (1984). Staphylococcus aureus. The persistent pathogen (first of two parts). N. Engl. J. Med. 310: 1368-1373.
24. Silva CL, Bonato VL, Coelho-Castelo AA, De Souza AO, et al. (2005). Immunotherapy with plasmid DNA encoding mycobacterial hsp65 in association with chemotherapy is a more rapid and efficient form of treatment for tuberculosis in mice. Gene Ther. 12: 281-287.
25. Swartz MN (1994). Hospital-acquired infections: diseases with increasingly limited therapies. Proc. Natl. Acad. Sci. USA 91: 2420-2427.
26. Tuteja R (1999). DNA vaccines: a ray of hope. Crit. Rev. Biochem. Mol. Biol. 34: 1-24.